BIOMAT Database Logo BIOMAT Database Logo

Lack of hepatotoxic interaction between the anticonvulsant drugs phenytoin, sodium valproate and phenobarbital in the rat. 1986

R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Metabolic interactions of phenytoin in the rat: effect of coadministration with the anticonvulsant drugs sodium valproate, sulthiame, ethosuximide or phenobarbital.
January 1984, General pharmacology,
R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate.
December 1998, British journal of pharmacology,
R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Interaction between phenytoin and valproate.
August 1980, The Medical journal of Australia,
R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Certain aspects of interaction between sodium valproate and other anticonvulsant drugs in the therapy of epilepsy in children.
January 1992, Materia medica Polona. Polish journal of medicine and pharmacy,
R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Pharmacodynamic interaction between phenytoin and sodium valproate changes seizure thresholds and pattern.
November 1998, British journal of pharmacology,
R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Interaction between valproate formulation and phenytoin concentrations.
January 1995, European journal of clinical pharmacology,
R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
March 1981, The Journal of pharmacology and experimental therapeutics,
R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Anticonvulsant activity of phenobarbital and phenytoin in combination.
March 1977, The Journal of pharmacology and experimental therapeutics,
R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Lack of pharmacokinetic interaction between remacemide hydrochloride and sodium valproate in epileptic patients.
June 1997, Seizure,
R M Walker, and R A Martin, and C J DiFonzo, and J M Sturgess, and F A de la Iglesia
Lack of interaction between ranitidine and phenytoin.
April 1983, British journal of clinical pharmacology,
Copied contents to your clipboard!